QIAGEN Price to Free Cash Flow Ratio 2006-2021 | QGEN

Historical price to free cash flow ratio values for QIAGEN (QGEN) since 2006. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
QIAGEN Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2022-01-25 47.79 21.14
2021-09-30 51.68 $2.26 22.86
2021-06-30 48.38 $1.80 26.89
2021-03-31 48.69 $1.76 27.67
2020-12-31 52.85 $1.39 38.08
2020-09-30 52.26 $0.77 67.64
2020-06-30 42.81 $1.05 40.59
2020-03-31 41.60 $0.83 50.13
2019-12-31 33.80 $0.94 36.00
2019-09-30 32.97 $0.91 36.06
2019-06-30 40.55 $0.86 47.42
2019-03-31 40.68 $1.03 39.31
2018-12-31 34.45 $1.07 32.21
2018-09-30 37.88 $0.97 39.15
2018-06-30 36.16 $0.98 36.97
2018-03-31 32.31 $0.78 41.31
2017-12-31 30.93 $0.84 36.63
2017-09-30 31.50 $0.97 32.63
2017-06-30 33.53 $1.06 31.65
2017-03-31 28.97 $1.18 24.58
2016-12-31 29.10 $1.12 26.03
2016-09-30 28.50 $0.99 28.87
2016-06-30 22.65 $1.00 22.54
2016-03-31 23.20 $0.87 26.53
2015-12-31 28.71 $0.92 31.17
2015-09-30 26.81 $0.90 29.64
2015-06-30 25.74 $0.87 29.69
2015-03-31 26.17 $0.88 29.65
2014-12-31 24.36 $0.83 29.37
2014-09-30 23.65 $0.87 27.19
2014-06-30 25.39 $0.81 31.25
2014-03-31 21.90 $0.74 29.61
2013-12-31 24.73 $0.75 33.04
2013-09-30 22.22 $0.68 32.84
2013-06-30 20.68 $0.63 32.62
2013-03-31 21.89 $0.78 27.95
2012-12-31 18.85 $0.62 30.30
2012-09-30 19.22 $0.68 28.48
2012-06-30 17.34 $0.66 26.34
2012-03-31 16.17 $0.54 30.14
2011-12-31 14.34 $0.70 20.63
2011-09-30 14.36 $0.76 18.79
2011-06-30 19.75 $1.05 18.83
2011-03-31 20.82 $0.83 25.23
2010-12-31 20.30 $0.76 26.81
2010-09-30 18.42 $0.55 33.32
2010-06-30 19.96 $0.71 27.96
2010-03-31 23.87 $0.75 31.70
2009-12-31 23.19 $0.71 32.49
2009-09-30 22.10 $1.03 21.39
2009-06-30 19.31 $0.50 38.47
2009-03-31 16.57 $0.73 22.65
2008-12-31 18.24 $0.69 26.33
2008-09-30 20.49 $0.32 63.32
2008-06-30 20.90 $0.30 69.38
2008-03-31 21.60 $0.13 169.15
2007-12-31 21.86 $0.25 88.39
2007-09-30 20.16 $0.72 28.17
2007-06-30 18.47 $0.63 29.25
2007-03-31 17.84 $0.59 29.99
2006-12-31 15.71 $0.49 31.76
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.128B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $138.972B 8.78
Bio-Rad Laboratories (BIO.B) United States $16.992B 34.48
Biohaven Pharmaceutical Holding (BHVN) United States $7.780B 0.00
Emergent Biosolutions (EBS) United States $2.486B 8.94
Arcus Biosciences (RCUS) United States $2.230B 0.00
Myovant Sciences (MYOV) United Kingdom $1.231B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.064B 0.00
Zymeworks (ZYME) Canada $0.466B 0.00
SQZ Biotechnologies (SQZ) United States $0.214B 0.00
Ambrx Biopharma (AMAM) United States $0.193B 0.00
Enzo Biochem (ENZ) United States $0.153B 19.75